Genomma Lab Internacional, S.A.B. de C.V.
GNMLF
$1.43
$0.169913.48%
| 06/30/2024 | 03/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 9.16% | 22.96% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 9.16% | 22.96% | |||
| Cost of Revenue | 13.11% | 6.58% | |||
| Gross Profit | 7.06% | 33.91% | |||
| SG&A Expenses | 4.60% | 45.58% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -251.18% | -102.35% | |||
| Total Operating Expenses | 8.18% | 21.96% | |||
| Operating Income | 12.99% | 27.00% | |||
| Income Before Tax | 60.56% | 403.03% | |||
| Income Tax Expenses | 43.46% | -10.56% | |||
| Earnings from Continuing Operations | 67.21% | 728.30% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 67.21% | 728.30% | |||
| EBIT | 12.99% | 27.00% | |||
| EBITDA | 8.47% | 33.25% | |||
| EPS Basic | 69.13% | 721.62% | |||
| Normalized Basic EPS | 62.00% | 412.82% | |||
| EPS Diluted | 69.13% | 721.62% | |||
| Normalized Diluted EPS | 62.00% | 412.82% | |||
| Average Basic Shares Outstanding | -1.19% | 1.49% | |||
| Average Diluted Shares Outstanding | -1.19% | 1.49% | |||
| Dividend Per Share | -- | 5.36% | |||
| Payout Ratio | -0.36% | 1.16% | |||
